Quantcast
Last updated on April 16, 2014 at 6:04 EDT

Latest Neurodegenerative disease Stories

2013-11-19 08:29:25

Non-Profit Leader Joins with Industry Innovator to Study Cancer Therapies for Devastating Brain Disease NEW YORK, Nov. 19, 2013 /PRNewswire/ -- Project A.L.S. today announced an agreement with Eli Lilly and Company aimed at helping to accelerate the development of potential therapies for the neurodegenerative disease amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. As part of the agreement, Project A.L.S. will study molecules developed and studied...

2013-10-08 13:25:02

Mechanism meant to maintain efficiency of brain network involved in neurodegenerative disease Scientists at the Montreal Neurological Institute and Hospital-The Neuro, McGill University, have made important discoveries about a cellular process that occurs during normal brain development and may play an important role in neurodegenerative diseases. The study’s findings, published in Cell Reports, a leading scientific journal, point to new pathways and targets for novel therapies for...

2013-08-19 12:25:16

BOSTON, Aug. 19, 2013 /PRNewswire/ -- Piramal Imaging announced today that the Company has submitted a detailed response to CMS regarding the draft decision to limit Medicare coverage of beta-amyloid PET imaging in dementia and neurodegenerative disease.(1) Piramal Imaging's response, originally submitted on Monday, July 29, 2013, has been posted on CMS' website as part of the public comment process, which was open through August 2, 2013. As of August 8, 2013, CMS' website indicated...

2013-08-14 11:54:45

The steady accumulation of a protein in healthy, aging brains may explain seniors' vulnerability to neurodegenerative disorders, a new study by researchers at the Stanford University School of Medicine reports. The study's unexpected findings could fundamentally change the way scientists think about neurodegenerative disease. The pharmaceutical industry has spent billions of dollars on futile clinical trials directed at treating Alzheimer's disease by ridding brains of a substance...

2013-07-25 12:27:53

Piramal Imaging Urges Public Participation During the CMS Public Comment Period on the use of Beta-Amyloid Imaging in Dementia BERLIN, BOSTON and MUMBAI, India, July 25, 2013 /PRNewswire/ -- On Wednesday, July 3, 2013, the Centers for Medicare & Medicaid Services (CMS) released its proposed decision memorandum regarding the use of beta-amyloid imaging in dementia and neurodegenerative disease.(1) Piramal Imaging is concerned about CMS' proposal, which appears to take an...

2012-08-14 02:29:46

CAMBRIDGE, Mass. and NEW YORK, Aug. 14, 2012 /PRNewswire/ -- GNS Healthcare, Inc. (GNS), the leading healthcare data analytics company focused on enabling personalized medicine to improve human health, today announced that it has entered into a collaboration with CHDI Foundation, Inc. (CHDI) to create a data-driven computer model of Huntington's disease (HD), a debilitating neurodegenerative disorder for which there are currently no effective therapies. Created using GNS's...

2012-07-26 02:30:20

ROCKVILLE, Md., July 26, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that it received a notice of issuance for patent number 12/710,097 titled: "Transplantation of Human Neural Cells for Treatment of Neurodegenerative Conditions." This patent covers both the culturing of central nervous system cells as well as their transplantation into spinal cord tissue to treat neurodegenerative conditions, including amytrophic lateral sclerosis (ALS or Lou Gehrig's disease). Neuralstem...

2012-07-23 20:52:59

A team of University of Alberta researchers has identified a new class of compounds that inhibit the spread of prions, misfolded proteins in the brain that trigger lethal neurodegenerative diseases in humans and animals. U of A chemistry researcher Frederick West and his team have developed compounds that clear prions from infected cells derived from the brain. "When these designer molecules were put into infected cells in our lab experiments, the numbers of misfolded proteins...

Skin Cells Create Stem Cells In Huntington Disease Study
2012-06-29 09:13:31

Connie K. Ho for redOrbit.com — Your Universe Online In 1993, the autosomal dominant gene mutation responsible for Huntington´s Disease (HD) was discovered. However, no treatments are known to slow its progression. New research may pave the way to better understanding of the disease. Researchers at Johns Hopkins recently announced that they were able to produce stem cells from skin cells from a person who had severe, early-onset form of HD; the cells were then changed into...

2012-06-29 06:15:57

(Ivanhoe Newswire) -- Using a human induced pluripotent stem cell (iPSC) from a patient suffering from Huntington´s disease, researchers at the Buck Institute for Research on Aging have corrected the genetic mutation that is responsible for the disease. To accomplish this process, researchers took the diseased iPSCs, made the genetic correction, generated neural stem cells, and then transplanted the mutation-free cells into a mouse model of Huntington´s disease where they are...